These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25409188)

  • 1. The long-term effects of pitavastatin on blood lipids and platelet activation markers in stroke patients: impact of the homocysteine level.
    Sugimoto H; Konno S; Nomoto N; Nakazora H; Murata M; Kitazono H; Imamura T; Inoue M; Sasaki M; Fuse A; Hagiwara W; Kobayashi M; Fujioka T
    PLoS One; 2014; 9(11):e113766. PubMed ID: 25409188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pitavastatin on adiponectin in patients with hyperlipidemia.
    Inami N; Nomura S; Shouzu A; Omoto S; Kimura Y; Takahashi N; Tanaka A; Nanba M; Shouda Y; Iwasaka T
    Pathophysiol Haemost Thromb; 2007; 36(1):1-8. PubMed ID: 18332608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitavastatin - a novel therapeutic milestone.
    Ohbayashi H
    Drugs Today (Barc); 2010 Oct; 46(10):765-75. PubMed ID: 21076713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study.
    Matsubara T; Naruse K; Arakawa T; Nakao M; Yokoi K; Oguri M; Marui N; Amano T; Ichimiya S; Ohashi T; Imai K; Sakai S; Sugiyama S; Ishii H; Murohara T
    J Cardiol; 2012 Nov; 60(5):389-94. PubMed ID: 22884685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients.
    Nomura S; Shouzu A; Omoto S; Inami N; Shimazu T; Satoh D; Kajiura T; Yamada K; Urase F; Maeda Y; Iwasaka T
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):440-7. PubMed ID: 19525846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Pitavastatin on Lipid-rich Carotid Plaques Studied Using High-resolution Magnetic Resonance Imaging.
    Feng T; Huang X; Liang Q; Liang Y; Yuan Y; Feng L; Wu W; Xiao X; Han Y
    Clin Ther; 2017 Mar; 39(3):620-629. PubMed ID: 28185713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
    Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
    Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
    da Silva PM
    Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitavastatin: an overview.
    Saito Y
    Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome.
    Nakamura T; Obata JE; Kitta Y; Takano H; Kobayashi T; Fujioka D; Saito Y; Kodama Y; Kawabata K; Mende A; Yano T; Hirano M; Sano K; Nakamura K; Kugiyama K
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):365-71. PubMed ID: 18427279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.
    Gumprecht J; Gosho M; Budinski D; Hounslow N
    Diabetes Obes Metab; 2011 Nov; 13(11):1047-55. PubMed ID: 21812889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing percutaneous coronary intervention.
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
    Am J Cardiol; 2013 Jun; 111(11):1570-5. PubMed ID: 23497779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitavastatin calcium: clinical review of a new antihyperlipidemic medication.
    Yee LL; Wright EA
    Clin Ther; 2011 Aug; 33(8):1023-42. PubMed ID: 21816477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study).
    Watanabe T; Kawasaki M; Tanaka R; Ono K; Kako N; Saeki M; Onishi N; Nagaya M; Sato N; Miwa H; Arai M; Noda T; Watanabe S; Minatoguchi S
    Cardiovasc Ultrasound; 2015 Apr; 13():17. PubMed ID: 25889304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
    Kurata T; Miyazaki K; Kozuki M; Panin VL; Morimoto N; Ohta Y; Nagai M; Ikeda Y; Matsuura T; Abe K
    Brain Res; 2011 Jan; 1371():161-70. PubMed ID: 21112317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonists.
    Yoshika M; Komiyama Y; Masuda M; Yokoi T; Masaki H; Ohkura H; Takahashi H
    Clin Exp Hypertens; 2010; 32(6):341-6. PubMed ID: 21028996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs.
    Xu C; Fang D; Chen X; Xinyue L; Nie Y; Xie Y; Ma Y; Deng S; Zhang Z; Song X
    Eur J Pharmacol; 2015 Sep; 762():364-71. PubMed ID: 26057693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients.
    Yamagami H; Sakaguchi M; Furukado S; Hoshi T; Abe Y; Hougaku H; Hori M; Kitagawa K
    Ultrasound Med Biol; 2008 Sep; 34(9):1353-9. PubMed ID: 18378381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.